Tag: Mubadala

Home » Mubadala » Page 2
Mubadala's Kelix Bio Acquires DiabTec from Julphar
Post

Mubadala’s Kelix Bio Acquires DiabTec from Julphar

Abu Dhabi’s Mubadala Investment Company, through its unit Kelix Bio, has finalized the acquisition of DiabTec, a subsidiary of Julphar. This move marks a significant step in strengthening Mubadala’s biologicals portfolio and advancing biomanufacturing in the MENA region. DiabTec’s advanced facility, equipped with 20,000-litre drug substance reactors and a dedicated cartridge fill-finish facility for drug...

Post

Mubadala Tops Global Wealth Fund Spending in 2024

Abu Dhabi’s Mubadala Investment Company has taken the lead as the world’s biggest spender among sovereign wealth funds in 2024. The fund deployed $29.2 billion last year, a sharp increase from $17.5 billion in 2023, according to a report by Global SWF, an industry tracker. This marks a significant shift, as Saudi Arabia’s Public Investment...